Workflow
MarketWatch
icon
Search documents
Gold hit a new record. What Deutsche Bank says is driving the price of the metal
MarketWatch· 2025-09-29 11:10
Core Insights - The price of gold has reached an all-time high, driven by significant demand from central banks and exchange-traded funds [1] Group 1: Market Drivers - Central banks are actively purchasing gold, contributing to the surge in prices [1] - Exchange-traded funds (ETFs) are also playing a crucial role in driving demand for gold [1]
Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating
MarketWatch· 2025-09-29 09:36
Core Viewpoint - Morgan Stanley analysts predict that a trial testing Novo Nordisk's weight-loss drug for effectiveness against Alzheimer's is likely to fail, setting the most pessimistic target price forecast among Wall Street banks for the company [1] Company Summary - Novo Nordisk is currently under scrutiny due to its weight-loss drug, which is being tested for potential Alzheimer's treatment [1] - The company's stock forecast has been marked down by Morgan Stanley, indicating a lack of confidence in the drug's success in the Alzheimer's trial [1] Industry Summary - The pharmaceutical industry is closely monitoring the outcomes of trials for drugs that may have multiple therapeutic uses, particularly in the context of weight-loss medications being repurposed for neurodegenerative diseases [1] - The results of such trials can significantly impact stock valuations and investor sentiment within the biotech and pharmaceutical sectors [1]
Months after cancer drug trial, Merus agrees to be bought at 41% premium
MarketWatch· 2025-09-29 09:34
Core Viewpoint - Merus has agreed to be acquired at a 41% premium following a successful trial of a cancer drug [1] Company Summary - The acquisition reflects confidence in Merus's recent positive trial results for its cancer drug, which may enhance its market position and investor interest [1] Industry Summary - The deal highlights ongoing consolidation trends in the biopharmaceutical industry, particularly in the oncology sector, as companies seek to bolster their drug pipelines through strategic acquisitions [1]
The Trump effect on share buybacks? There's more of them.
MarketWatch· 2025-09-29 09:16
Core Insights - Gavekal Research anticipates an increase in stock repurchases, which is expected to provide additional support for the ongoing bull market [1] Group 1 - The prediction of more stock buybacks indicates a positive sentiment among companies, potentially leading to higher stock prices [1] - Increased stock repurchases can enhance shareholder value and signal confidence in future earnings [1] - The trend of stock buybacks may contribute to a favorable market environment, reinforcing the current bullish momentum [1]
GSK turns to insider to be next CEO — and the stock rallies
MarketWatch· 2025-09-29 08:46
Core Viewpoint - Shares of U.K. pharmaceutical giant GSK experienced a rally following the announcement of an insider being appointed as the next CEO [1] Company Summary - GSK is a major player in the pharmaceutical industry, and the recent leadership change is seen as a strategic move to stabilize and enhance company performance [1]
U.S. stock futures little changed as investors eye possible government shutdown
MarketWatch· 2025-09-28 22:19
Core Viewpoint - U.S. stock-market futures are flat as investors await potential government shutdown later this week [1] Group 1 - Investors are closely monitoring the situation regarding a possible government shutdown [1]
The last thing the stock market wants right now is a government shutdown. Here's why.
MarketWatch· 2025-09-28 16:00
Core Insights - Stocks are showing resilience in September, which is typically a weak month for the market, indicating potential strength heading into October [1] Group 1 - Historical trends suggest that September is usually a challenging month for stocks, but current performance is defying this norm [1] - The market's ability to maintain strength in September may set a positive tone for October, traditionally a stronger month for equities [1] - Analysts are observing this unusual trend closely, as it could signal a shift in market dynamics [1]
The AI hype is starting to fade on Wall Street. Here's what investors need to know.
MarketWatch· 2025-09-27 13:19
Core Viewpoint - There are growing doubts on Wall Street regarding the sustainability of the artificial intelligence trade, despite the market's current performance [1] Group 1 - The market's action may not reflect the underlying concerns about artificial intelligence investments [1]
Recession seems far off — that's the good news. Yet the economy is also far from trouble-free.
MarketWatch· 2025-09-27 13:00
Core Insights - The Federal Reserve decided to cut interest rates due to emerging trouble spots in the U.S. economy, indicating a cautious approach to economic conditions [1] Economic Indicators - Despite the decision to lower interest rates, the overall economic news is not as negative as it may seem, suggesting resilience in certain sectors [1]